APA (7th ed.) Citation

A, A., GG, K., AR, B., Y, B., M, H., & M, A. (2026). Morbidity and Mortality of Ondansetron in Patients with Non-congenital Long QT Syndrome: A Review Article. Cardiovascular drugs and therapy, 40(3), 1117. https://doi.org/10.1007/s10557-025-07766-2

Chicago Style (17th ed.) Citation

A, Al-Ramadan, Kidess GG, Bahar AR, Bahar Y, Hazique M, and Alraies M. "Morbidity and Mortality of Ondansetron in Patients with Non-congenital Long QT Syndrome: A Review Article." Cardiovascular Drugs and Therapy 40, no. 3 (2026): 1117. https://doi.org/10.1007/s10557-025-07766-2.

MLA (9th ed.) Citation

A, Al-Ramadan, et al. "Morbidity and Mortality of Ondansetron in Patients with Non-congenital Long QT Syndrome: A Review Article." Cardiovascular Drugs and Therapy, vol. 40, no. 3, 2026, p. 1117, https://doi.org/10.1007/s10557-025-07766-2.